We have now completed our journey across Denmark, Sweden, Finland and Norway.
Four countries.
Four distinct strengths.
One shared evidence philosophy.
Denmark ā deeply integrated national registries and a strong epidemiological tradition
Swedenā clinically rich quality registries embedded in routine care
Finland ā structured secondary-use frameworks [ā¦]
Norway closes our Nordic RWD series for a reason.
A universal healthcare system, personal identifiers, and decades of national coverage enable true longitudinal follow-up across care settings.
This is not just data availability.
It is [ā¦]
Quantify Research will be attending the World Evidence, Pricing and Access Congress in šAmsterdam, š March 3ā4.
BĆ©ranger Lueza, PhD & Abraham Choong will represent Quantify on site.
You will find us at Booth 302, together [ā¦]
This is the third installment of the RWD sources from the Nordics. This weekās highlight is Finlandās real-world data ecosystem; which is built on something rare: continuity.
š Since the 1960s, nationwide health [ā¦]
Denmark offers one of the worldās most robust environments for real-world evidence generation. Key strengths include:
1ļøā£ Fast access to comprehensive data
The average time to fully process applications at the Danish Health Data [ā¦]
This Wednesday, we gathered in Stockholm for the Quantify Research 2026 Kick-Off.
Colleagues joined from Finland, Norway and Denmark, with our India team participating online.
We reflected on a strong 2025.
Then we set clear priorities for the year ahead.
Our focus remains clear [ā¦]
Swedenās RWD ecosystem is one of the most powerful globally ā rich in coverage, high in trust, and fully linkable across registers via the personal identity number unique to every resident.
Thousands of [ā¦]
šNew colleague ināÆHEOR & Market Access
This week, weāre pleased to welcome Petri Niinisalo, PhD to Quantify!
He joins our MAS team in Helsinki, bringing deep expertise in:
ā¾ āÆHealth economic modelling
ā¾ āÆPrice & reimbursement [ā¦]
Ā
Come meet our Quantify Research team: ready to talk real-world data, access, and the role of AI in smarter drug development.
From the mainstage to breakout sessions, weāre [ā¦]
š§ Strategic insight incoming: Gabriella Strand joins Quantify as Project Leader in Modelling, Access & Strategy (MAS) team.
Weāre thrilled to welcome Gabriella Chauca Strand to Quantify Research, where sheāll bring her sharp mind and strategic mindset to our Access and [ā¦]